| Application no. and date | 20721083.2 (espacenet) (Federated) (European Patent Register), 20200408 | | Patent/reg. no. and date | DK/EP 3953357, 20240417 | | Publication date | 20220216 | | Priority no. and date | US 201962833529 P, 20190412, US 201962911016 P, 20191004, US 201962930240 P, 20191104 | | EP pub. no. and date |
EP 3953357 20220216 | | Effective date | | | Applicant/owner | Blueprint Medicines Corporation, 45 Sidney Street
Cambridge, MA 02139, US | | Applicant ref. no. | 24039DK00 | | Inventor | KIM, Joseph, L., 45 Sidney Street
Cambridge, MA 02139, US,
DINEEN, Thomas, A., 45 Sidney Street
Cambridge, MA 02139, US,
GUZI, Timothy, 45 Sidney Street
Cambridge, MA 02139, US | | Representative | Inspicos P/S, Agern Alle 24 , 2970 Hørsholm | | Opponent | | | IPC Class | A61K 31/53 (2006.01) , A61P 35/00 (2006.01) , C07D 487/04 (2006.01) | | Title | Pyrrolotriazine derivatives for treating KIT- and PDGFRA-mediated diseases | | Int. application no. | US2020027177 | | Int. publication no. | WO2020210293 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
